| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.49e-05 | 22 | 44 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.49e-05 | 22 | 44 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 6.77e-05 | 36 | 44 | 3 | GO:0015035 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 1.16e-04 | 43 | 44 | 3 | GO:0015036 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.40e-04 | 120 | 44 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 2.69e-04 | 57 | 44 | 3 | GO:0016860 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 2.69e-04 | 57 | 44 | 3 | GO:0016667 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 9.69e-04 | 200 | 44 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.46e-03 | 430 | 44 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | histone binding | 2.71e-03 | 265 | 44 | 4 | GO:0042393 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.96e-05 | 656 | 45 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.11e-05 | 658 | 45 | 8 | GO:0030312 | |
| Domain | TSP_1 | 1.40e-12 | 63 | 43 | 8 | PF00090 | |
| Domain | TSP1 | 1.81e-12 | 65 | 43 | 8 | SM00209 | |
| Domain | TSP1_rpt | 1.81e-12 | 65 | 43 | 8 | IPR000884 | |
| Domain | TSP1 | 1.81e-12 | 65 | 43 | 8 | PS50092 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.09e-09 | 24 | 43 | 5 | IPR013273 | |
| Domain | PLAC | 2.40e-08 | 14 | 43 | 4 | PF08686 | |
| Domain | PLAC | 9.20e-08 | 19 | 43 | 4 | IPR010909 | |
| Domain | PLAC | 9.20e-08 | 19 | 43 | 4 | PS50900 | |
| Domain | ADAM_spacer1 | 2.09e-07 | 23 | 43 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.09e-07 | 23 | 43 | 4 | PF05986 | |
| Domain | Thioredoxin_CS | 7.56e-06 | 17 | 43 | 3 | IPR017937 | |
| Domain | THIOREDOXIN_1 | 2.52e-05 | 25 | 43 | 3 | PS00194 | |
| Domain | Thioredoxin | 4.88e-05 | 31 | 43 | 3 | PF00085 | |
| Domain | Peptidase_M12B_N | 9.80e-05 | 39 | 43 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.80e-05 | 39 | 43 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.06e-04 | 40 | 43 | 3 | PS00427 | |
| Domain | ADAM_MEPRO | 1.06e-04 | 40 | 43 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.06e-04 | 40 | 43 | 3 | PS50214 | |
| Domain | Reprolysin | 1.06e-04 | 40 | 43 | 3 | PF01421 | |
| Domain | Peptidase_M12B | 1.06e-04 | 40 | 43 | 3 | IPR001590 | |
| Domain | Thioredoxin_domain | 1.14e-04 | 41 | 43 | 3 | IPR013766 | |
| Domain | Disintegrin_dom | 1.14e-04 | 41 | 43 | 3 | IPR001762 | |
| Domain | THIOREDOXIN_2 | 1.32e-04 | 43 | 43 | 3 | PS51352 | |
| Domain | Disulphide_isomerase | 1.44e-04 | 8 | 43 | 2 | IPR005788 | |
| Domain | Thioredoxin | 3.97e-04 | 13 | 43 | 2 | IPR005746 | |
| Domain | MetalloPept_cat_dom | 8.56e-04 | 81 | 43 | 3 | IPR024079 | |
| Domain | - | 8.56e-04 | 81 | 43 | 3 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.48e-03 | 98 | 43 | 3 | PS00142 | |
| Domain | - | 2.77e-03 | 122 | 43 | 3 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 3.46e-03 | 132 | 43 | 3 | IPR012336 | |
| Domain | LDLR_class-A_CS | 3.82e-03 | 40 | 43 | 2 | IPR023415 | |
| Domain | CYSTEINE_SWITCH | 4.01e-03 | 41 | 43 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 4.40e-03 | 43 | 43 | 2 | IPR001818 | |
| Domain | Ldl_recept_a | 4.81e-03 | 45 | 43 | 2 | PF00057 | |
| Domain | - | 5.03e-03 | 46 | 43 | 2 | 4.10.400.10 | |
| Domain | ER_TARGET | 5.24e-03 | 47 | 43 | 2 | PS00014 | |
| Domain | LDLRA_1 | 5.46e-03 | 48 | 43 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.69e-03 | 49 | 43 | 2 | IPR002172 | |
| Domain | LDLa | 5.69e-03 | 49 | 43 | 2 | SM00192 | |
| Domain | LDLRA_2 | 5.69e-03 | 49 | 43 | 2 | PS50068 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS18 ADAMTSL1 THSD7B THSD7A ADAMTS6 ADAMTS9 MUC4 NOTCH2 ADAMTSL2 | 6.93e-14 | 68 | 36 | 9 | M27303 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.53e-12 | 39 | 36 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.53e-12 | 39 | 36 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS18 ADAMTSL1 THSD7B THSD7A ADAMTS6 ADAMTS9 MUC4 NOTCH2 ADAMTSL2 | 6.58e-11 | 143 | 36 | 9 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS18 ADAMTSL1 THSD7B THSD7A ADAMTS6 ADAMTS9 MUC4 ADAMTSL2 | 2.49e-10 | 109 | 36 | 8 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS18 ADAMTSL1 THSD7B THSD7A ADAMTS6 ADAMTS9 MUC4 ADAMTSL2 | 2.88e-10 | 111 | 36 | 8 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS18 ADAMTSL1 THSD7B THSD7A ADAMTS6 ADAMTS9 MUC4 NOTCH2 ADAMTSL2 | 9.32e-09 | 250 | 36 | 9 | M27554 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS18 LYPD6B PDIA6 ADAMTSL1 THSD7B KDM1B THSD7A ADAMTS6 ADAMTS9 MUC4 ZRANB1 ADAMTSL2 | 1.05e-04 | 1389 | 36 | 12 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS18 LYPD6B PDIA6 ADAMTSL1 THSD7B KDM1B THSD7A ADAMTS6 ADAMTS9 MUC4 ZRANB1 ADAMTSL2 | 1.88e-04 | 1475 | 36 | 12 | M19806 |
| Pubmed | 6.92e-12 | 75 | 45 | 7 | 20637190 | ||
| Pubmed | 1.12e-06 | 16 | 45 | 3 | 23245351 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 27417586 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23036009 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19198611 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 14667842 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 27316341 | ||
| Pubmed | 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. | 4.91e-06 | 3 | 45 | 2 | 7679504 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 19887585 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 9858544 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 21900290 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 16507336 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 20101243 | ||
| Pubmed | 1.63e-05 | 5 | 45 | 2 | 21057456 | ||
| Pubmed | Genetic and clinical correlates of early-outgrowth colony-forming units. | 1.63e-05 | 5 | 45 | 2 | 21493818 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.96e-05 | 1201 | 45 | 9 | 35696571 | |
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 19247373 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 18567820 | ||
| Pubmed | 2.45e-05 | 6 | 45 | 2 | 23134681 | ||
| Pubmed | CHIP ubiquitylates NOXA and induces its lysosomal degradation in response to DNA damage. | 5.82e-05 | 162 | 45 | 4 | 32913203 | |
| Pubmed | Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes. | 5.86e-05 | 9 | 45 | 2 | 18714373 | |
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 11167130 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 36427672 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 19670153 | ||
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 15937668 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.07e-04 | 12 | 45 | 2 | 25770910 | |
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 19833888 | ||
| Pubmed | 1.94e-04 | 16 | 45 | 2 | 30579834 | ||
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 19502414 | ||
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 19741467 | ||
| Pubmed | Genome-wide association analysis of age-at-onset in Alzheimer's disease. | 2.20e-04 | 17 | 45 | 2 | 22005931 | |
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 21897333 | ||
| Pubmed | 2.47e-04 | 18 | 45 | 2 | 19324937 | ||
| Pubmed | Genome-wide association study of chronic periodontitis in a general German population. | 2.66e-04 | 96 | 45 | 3 | 24024966 | |
| Pubmed | Clinical risk factors, DNA variants, and the development of type 2 diabetes. | 2.76e-04 | 19 | 45 | 2 | 19020324 | |
| Pubmed | Genome-wide association study of liver enzymes in korean children. | 2.76e-04 | 19 | 45 | 2 | 24124411 | |
| Pubmed | 2.76e-04 | 19 | 45 | 2 | 19139842 | ||
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 20075150 | ||
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 19862325 | ||
| Pubmed | Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. | 3.06e-04 | 20 | 45 | 2 | 19933996 | |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 3.13e-04 | 460 | 45 | 5 | 20562862 | |
| Pubmed | Genotype score in addition to common risk factors for prediction of type 2 diabetes. | 3.38e-04 | 21 | 45 | 2 | 19020323 | |
| Pubmed | 3.38e-04 | 21 | 45 | 2 | 18591388 | ||
| Pubmed | Underlying genetic models of inheritance in established type 2 diabetes associations. | 3.38e-04 | 21 | 45 | 2 | 19602701 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 3.39e-04 | 468 | 45 | 5 | 31056421 | |
| Pubmed | 3.72e-04 | 22 | 45 | 2 | 34998785 | ||
| Pubmed | 3.72e-04 | 22 | 45 | 2 | 19794065 | ||
| Pubmed | Mapping wild-type and R345W fibulin-3 intracellular interactomes. | 3.72e-04 | 22 | 45 | 2 | 27777122 | |
| Pubmed | 3.72e-04 | 22 | 45 | 2 | 18372903 | ||
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 19720844 | ||
| Pubmed | 4.29e-04 | 493 | 45 | 5 | 15368895 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.34e-04 | 1425 | 45 | 8 | 30948266 | |
| Pubmed | 4.82e-04 | 25 | 45 | 2 | 20879858 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 4.82e-04 | 25 | 45 | 2 | 15820306 | |
| Pubmed | 5.76e-04 | 1487 | 45 | 8 | 33957083 | ||
| Pubmed | 6.06e-04 | 28 | 45 | 2 | 28655764 | ||
| Pubmed | Obesity and diabetes genetic variants associated with gestational weight gain. | 6.50e-04 | 29 | 45 | 2 | 20816152 | |
| Pubmed | 7.43e-04 | 31 | 45 | 2 | 23142642 | ||
| Pubmed | Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. | 8.43e-04 | 33 | 45 | 2 | 20203524 | |
| Pubmed | Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. | 1.00e-03 | 36 | 45 | 2 | 25715395 | |
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 1.12e-03 | 38 | 45 | 2 | 18267097 | |
| Cytoband | 6p22.3 | 9.46e-04 | 46 | 45 | 2 | 6p22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q22 | 1.71e-03 | 62 | 45 | 2 | chr13q22 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.92e-06 | 19 | 30 | 3 | 50 | |
| GeneFamily | Protein disulfide isomerases | 5.37e-06 | 21 | 30 | 3 | 692 | |
| GeneFamily | ADAMTS like | 5.56e-05 | 7 | 30 | 2 | 947 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 4.01e-04 | 18 | 30 | 2 | 624 | |
| Coexpression | NABA_ECM_REGULATORS | 3.19e-06 | 238 | 45 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.51e-06 | 242 | 45 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.26e-05 | 738 | 45 | 8 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.69e-05 | 751 | 45 | 8 | M5885 | |
| Coexpression | NABA_MATRISOME | ADAMTS18 ADAMTSL1 ADAMTS6 ADAMTS9 MUC4 OTOGL LPA ADAMTSL2 CLEC12B | 4.52e-05 | 1008 | 45 | 9 | MM17056 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 4.56e-05 | 115 | 45 | 4 | M45752 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | 1.26e-04 | 458 | 45 | 6 | M4785 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.35e-04 | 152 | 45 | 4 | M39243 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.62e-07 | 169 | 45 | 5 | d161dd8eb22633392b6c6466ee9eff4042464149 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.80e-07 | 174 | 45 | 5 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.85e-07 | 178 | 45 | 5 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 179 | 45 | 5 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-06 | 182 | 45 | 5 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-06 | 183 | 45 | 5 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-06 | 183 | 45 | 5 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-06 | 183 | 45 | 5 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-06 | 184 | 45 | 5 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 185 | 45 | 5 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 185 | 45 | 5 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 185 | 45 | 5 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 185 | 45 | 5 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-06 | 187 | 45 | 5 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-06 | 188 | 45 | 5 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-06 | 188 | 45 | 5 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-06 | 191 | 45 | 5 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-06 | 191 | 45 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 192 | 45 | 5 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-06 | 196 | 45 | 5 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.75e-06 | 200 | 45 | 5 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-06 | 200 | 45 | 5 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-06 | 200 | 45 | 5 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 154 | 45 | 4 | d883b3e2a65e4375bea1216eb9bbc86c64ee449c | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 157 | 45 | 4 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 157 | 45 | 4 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-05 | 161 | 45 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 164 | 45 | 4 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 167 | 45 | 4 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.50e-05 | 56 | 45 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-05 | 170 | 45 | 4 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 170 | 45 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-05 | 170 | 45 | 4 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 171 | 45 | 4 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 173 | 45 | 4 | b2c55084ef6dac0e329c2e65c24cfe0045859c30 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 173 | 45 | 4 | 120dd20e8a71f9169a1596b6171df7aa0b96dd15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 175 | 45 | 4 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 175 | 45 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-05 | 176 | 45 | 4 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-05 | 177 | 45 | 4 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-05 | 177 | 45 | 4 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 178 | 45 | 4 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 178 | 45 | 4 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 179 | 45 | 4 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 179 | 45 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 179 | 45 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 179 | 45 | 4 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 179 | 45 | 4 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 180 | 45 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 180 | 45 | 4 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 182 | 45 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 182 | 45 | 4 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.46e-05 | 183 | 45 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.54e-05 | 184 | 45 | 4 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-05 | 185 | 45 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-05 | 185 | 45 | 4 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 185 | 45 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 186 | 45 | 4 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 187 | 45 | 4 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-05 | 187 | 45 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 188 | 45 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 45 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 45 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.93e-05 | 189 | 45 | 4 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 190 | 45 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-05 | 190 | 45 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.18e-05 | 192 | 45 | 4 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.18e-05 | 192 | 45 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.18e-05 | 192 | 45 | 4 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.18e-05 | 192 | 45 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 4.35e-05 | 194 | 45 | 4 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.35e-05 | 194 | 45 | 4 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-05 | 194 | 45 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-05 | 194 | 45 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.44e-05 | 195 | 45 | 4 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 195 | 45 | 4 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 196 | 45 | 4 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 196 | 45 | 4 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-05 | 197 | 45 | 4 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-05 | 197 | 45 | 4 | 0d1afd1ad7489c071db08b3dfff598423097d7e0 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 197 | 45 | 4 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.62e-05 | 197 | 45 | 4 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.62e-05 | 197 | 45 | 4 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.62e-05 | 197 | 45 | 4 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.62e-05 | 197 | 45 | 4 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.71e-05 | 198 | 45 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 4.80e-05 | 199 | 45 | 4 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 4.80e-05 | 199 | 45 | 4 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | 527aae1d9d37a50deefc01fc0c064a53673681bd | |
| ToppCell | 15-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 4.80e-05 | 199 | 45 | 4 | 01bc88d9da528e5842b415a32b519b7f53e4cbab | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | e1fca7ee2dc18c7fded53c3561f519c1fcd9767a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | dd68ce6934eafb75d918042fcf7fd7a750294b7f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | 9f21e4e0913d8ef95a3f771dff0abaad8fe1d9f2 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-LBH-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | de23a5d22d94935802b5b84a9e029b3f62c57028 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.89e-05 | 200 | 45 | 4 | c1797542541747b524c9c22c723d24c8d027d486 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 2.27e-05 | 5 | 45 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 4.75e-05 | 7 | 45 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | Facies | 1.02e-04 | 10 | 45 | 2 | C0282631 | |
| Disease | Manic Disorder | 1.76e-04 | 71 | 45 | 3 | C0024713 | |
| Disease | Manic | 2.33e-04 | 78 | 45 | 3 | C0338831 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 2.36e-04 | 15 | 45 | 2 | EFO_0022328 | |
| Disease | Depression, Bipolar | 2.42e-04 | 79 | 45 | 3 | C0005587 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.05e-04 | 17 | 45 | 2 | EFO_0022232 | |
| Disease | energy expenditure measurement | 4.25e-04 | 20 | 45 | 2 | EFO_0008005 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.69e-04 | 21 | 45 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.69e-04 | 21 | 45 | 2 | EFO_0022246 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 4.69e-04 | 21 | 45 | 2 | EFO_0022262 | |
| Disease | R-warfarin measurement | 7.09e-04 | 265 | 45 | 4 | EFO_0803324 | |
| Disease | brain cancer (implicated_via_orthology) | 7.22e-04 | 26 | 45 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 7.22e-04 | 26 | 45 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | longevity, healthspan, parental longevity | 8.99e-04 | 29 | 45 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | anxiety disorder | 9.63e-04 | 30 | 45 | 2 | EFO_0006788 | |
| Disease | presubiculum volume | 1.03e-03 | 31 | 45 | 2 | EFO_0009400 | |
| Disease | intraocular pressure measurement | 1.04e-03 | 509 | 45 | 5 | EFO_0004695 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.24e-03 | 34 | 45 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.24e-03 | 34 | 45 | 2 | EFO_0008317, EFO_0008596, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSLSPWKCPWFVYCF | 6 | A4D1N5 | |
| CKWQGLPYSECSWED | 411 | O14646 | |
| CNAFSCPAYWMPGEW | 926 | Q8TE60 | |
| PQWVALDWSECTPKC | 961 | Q9UKP5 | |
| KTSPVYWCREDWPNQ | 301 | Q9Y5X5 | |
| CCWEYVVQWNKDPEE | 1016 | Q9H2M9 | |
| EPQSWCCRWNDKPYL | 4646 | Q99102 | |
| NPWANCSSPLPCWDY | 1461 | Q04721 | |
| WPSEYPAKINCSWFI | 66 | Q9Y561 | |
| MYPNPLIYCTCWDPW | 1 | Q96Q35 | |
| RWQYKCCWSPVADAN | 66 | Q2M2H8 | |
| AYAWAAQGPCSCSKW | 481 | A6NDA9 | |
| PCNIFDCPKWLAQEW | 431 | Q8N6G6 | |
| DCPKWLAQEWSPCTV | 436 | Q8N6G6 | |
| CYWNPYWMLPSDVCG | 81 | Q4G148 | |
| ERPCFKWYTSPWSEC | 851 | Q86TH1 | |
| WCDVNSPYVQPVGWC | 236 | Q8NA19 | |
| FPCPQWKSGDWSECL | 1051 | Q9P2N4 | |
| EVYSRANEKEPCCWW | 66 | Q06787 | |
| LPYWVQCTKPECRKW | 136 | Q8NB78 | |
| CCTIDWFQSWPTDAL | 2586 | Q8TD57 | |
| VNCQWDFYAPWSECN | 26 | P10643 | |
| NDTCKSCWAYWILPI | 116 | O43169 | |
| CKDCVPETLWELGYW | 391 | P11229 | |
| PWCYTMDPNVRWEYC | 1226 | P08519 | |
| PWCYTMDPSVRWEYC | 1446 | P08519 | |
| WLKCVCYQRVPWYPT | 356 | Q6ZNC8 | |
| PYKCTWEGCTWKFAR | 346 | Q9Y4X4 | |
| CWSVAACPEEWKYPL | 241 | Q96MH7 | |
| KCYVPESCPCIWKDW | 901 | Q3ZCN5 | |
| ESCPCIWKDWEYLSG | 906 | Q3ZCN5 | |
| YAPWCGHCKNLEPEW | 186 | Q15084 | |
| PTYWPWLCAAAQVAA | 66 | O00198 | |
| PCPSDCKLSEWSNWS | 1031 | Q9UPZ6 | |
| CPGDCYLKDWSSWSL | 1411 | Q9UPZ6 | |
| PWCYTTDPNVRWEYC | 86 | Q16609 | |
| CYKVPEWCLDDWHPS | 96 | Q9Y6M9 | |
| AWTTWPCEYKQCPLY | 481 | Q9HAT2 | |
| DSKEWPYCSQCPAVW | 491 | O00186 | |
| SDHRCNPCPKMWQWY | 136 | Q2HXU8 | |
| WECSCTIVPFKQWAE | 531 | Q96PX8 | |
| FQPVPSWCECAIYLW | 821 | O94759 | |
| PPCWYKFANMCLIWD | 726 | Q99250 | |
| YAPWCGHCKTLAPTW | 346 | Q8NBS9 | |
| SEWGLWSKCPQSCDP | 1131 | Q9C0I4 | |
| DWMIEFYAPWCPACQ | 46 | Q9H3N1 | |
| IKWACEYCTYENWPS | 6 | Q9UGI0 | |
| TAVDPWASWALCPQY | 21 | Q8WXB4 | |
| KPYKCTWEGCDWRFA | 401 | Q13887 | |
| RWAEDKWCPQNTQYC | 76 | Q8NI32 |